ReviewViruses2021

Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective.

Colin D Funk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.